Oxford expands the Cartography collaboration with Janssen
6 June 2022
The University of Oxford announced today that it has expanded a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation
Multiplex Serology: the first step towards looking at 20 infectious agents in half a million people
27 May 2022
Certain infectious agents are recognised causes of cancer and other chronic diseases. To understand the pathological mechanisms underlying such relationships, we designed a Multiplex Serology platform to measure quantitative antibody responses against 45 antigens from 20 infectious agents.
Outbreak: fighting coronavirus
13 February 2020
In a new Oxford Science Blog, Charvy Narain (Communications & Public Engagement Manager, Radcliffe Department of Medicine) talks to some of the Oxford University researchers coming together to fight the novel Coronavirus outbreak.
Researchers find new cells that repair tissue
18 September 2019
Researchers from Nuffield Department of Medicine have discovered that a newly discovered group of cells can help repair tissues in the body.
Rapidly spreading multidrug-resistant parasites render frontline malaria drug ineffective in southeast Asia
23 July 2019
A rapidly evolving multi-drug resistant lineage of P. falciparum malaria parasites continues to spread in South East Asia, leading to alarmingly high treatment failure rates in Cambodia, Thailand and Vietnam for DHA-piperaquine, one of the world’s most important anti-malaria drugs.
New study shows faster way to cure vivax malaria
19 July 2019
A large clinical trial in Africa and Asia has shown that a 7 day course of high dose primaquine, a drug used to treat P. vivax malaria, is well tolerated and just as effective as the current standard 14 day regimen, according to a study published this week in The Lancet. These findings have important implications for the treatment and elimination of vivax malaria in the Asia Pacific.
Award-winning citizen science project tackling TB gets millionth classification
5 October 2018
An award-winning Oxford-based international project to tackle antibiotic resistance has achieved its one millionth classification.
UK-led study marks shift towards genetic era in tackling TB
28 September 2018
In a landmark study that may herald a quicker, more tailored treatment for the millions of people around the world living with tuberculosis (TB), UK researchers have shown how our understanding of TB’s genetic code is now so detailed that we can now predict which commonly used anti-TB drugs are best for treating a patient’s infection and which are not.
MAIT cells protect against pulmonary Legionella longbeachae infection
23 August 2018
New paper published in Nature Communications from researchers in Respiratory Medicine Unit, NDM Experimental Medicine'
Malaria’s ticking time bomb
27 July 2018
Scientists are racing to stamp out the disease in Southeast Asia before unstoppable strains spread.